🔎 Trials Near Me

Dachaigh › Sclerosis iomaill

Sgrùdaidhean clionaigeach Sclerosis iomaill a’ fastadh anns na SA

Tha 131 sgrùdaidhean airson Sclerosis iomaill a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.

Bailtean leis na sgrùdaidhean as motha

Le stàit

Sgrùdaidhean air an ùrachadh o chionn ghoirid

Teacsa sgrùdaidh oifigeil (Beurla)

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

A’ fastadhÌre 2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT02784210

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study of the MIND Diet for Persons With Multiple Sclerosis

A’ fastadh
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06992115

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
1 Month – 99 Years · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT00794352

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT03109288

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06782490

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07609719

Vancomycin Study in Multiple Sclerosis (MS)

A’ fastadhÌre 1
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05539729

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07840326

Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis

A’ fastadh
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07475377

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06433752

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07477639

A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)

A’ fastadhSgrùdadh amharc
Aoisean 15 gu 50 · Banairean · Air ùrachadh 21 Sult 2026 · NCT06433765

Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis

A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07606742

Clinical Applications of Advanced Ophthalmic Imaging

A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT03135327

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT00001248

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05958381

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07002034

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06999434

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06680037

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 120 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT01730131

Identifying and Characterizing Preclinical MS

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT05787795

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.